Discover unparalleled sensitivity and specificity with BÜHLMANN’s Gold Standard «Anti-MAG Antibodies ELISA». Endorsed by experts as the preferred technique for testing anti-neural antibodies and recommended in various clinically relevant guidelines, this test is backed by over 75 published reviews and clinical/scientific studies and guidelines.

Our ELISA, now available in a Triton-X100-free version (Bantleon S. et al., 2024, Poster presented at the Annual Conference of the Peripheral Nerve Society, Montreal, Canada), fully complies with IVDR regulations. It maintains the same safety standards, regulatory adherence, and performance as the previous anti-MAG Antibody ELISA containing Triton, ensuring seamless continuity and reliability. The anti-MAG Antibody ELISA demonstrates significantly higher sensitivity than Western Blot (Kuijf M. et al., 2009). Using human MAG antigen, our ELISA outperforms Western Blot and IFA assays with primate antigen, providing superior sensitivity and specificity (Jaskowsky T. et al., 2008; Kuijf M. et al., 2009). It detects even low antibody titers, offering critical insights into neuropathies.

Application of the BÜHLMANN anti-MAG Antibodies ELISA ensures to minimize the risk of missing MAG antibody-associated pathologies in suspected neuropathy cases.

• Instructions for use
• More information
• Literature